Gambaran Umum, Prevalensi, dan Pencegahan Antraks pada Manusia di Indonesia
Abstract
Anthrax is a neglected zoonotic disease that remains a global issue because it can cause regular epidemics. Anthrax affects not only health systems but also social-economic conditions, safety, and welfare of the people. This paper aimed to give an overview of human anthrax, prevalence, and prevention in Indonesia. A literature search was performed using search engines such as Google Scholar, Crossref, Mendeley, PLoS One, Elsevier, dan the Ministry of Health official website. The literature used were published between 2015-2020. Anthrax is caused by Bacillus anthracis that affects animals and humans. The virulence factors of these bacteria are determined by the tripartite toxin complex and poly-γ-D-glutamic acid capsule. Anthrax in humans can be found in four forms, namely cutaneous, gastrointestinal, inhalational, and injection anthrax. Each form of anthrax can develop into meningitis and sepsis. Anthrax treatment is commonly done by administering antibiotics. In Indonesia, 14 provinces have been declared anthrax endemic areas. The prevalence of human anthrax in Indonesia is fluctuating and most of it is cutaneous anthrax. Prevention and control of anthrax can be done mainly by vaccination, obeying the rules or standard operating procedures of the authorities, multisectoral cooperation, strengthening anthrax surveillance, increasing resources for diagnosis, increasing public knowledge, and awareness.
References
2. Abawi I, Fibriana AI. Analisis spasial faktor lingkungan fisik daerah endemik antraks. HIGEIA. 2019;3(2):190-201.
3. Olani A, Dawo F, Lakew M. Laboratory diagnostic methods and reported outbreaks of anthrax in Ethiopia. European Journal of Biological Research. 2020;10(2):81-95.
4. Yu D, He J, Zhang E, Wang P, Liu D, Hou Y, et al. Investigation and source-tracing of an anthrax outbreak in Gansu Province, China. PLoS One. 2018;13(8):1-9.
5. Barro AS, Fegan M, Moloney B, Porter K, Muller J, Warner S, et al. Redefining the Australian anthrax belt: modeling the ecological niche and predicting the geographic distribution of Bacillus anthracis. PLoS Negl Trop Dis. 2016;10(6):e0004689. doi:10.1371/journal.pntd.0004689.
6. Yadeta W, Giro A, Amajo M, Jilo K. Recent understanding of the epidemiology of animal and human anthrax in Ethiopia with emphasis on diagnosis, control and prevention interventions-review. World Journal of Medical Sciences. 2020;17(1):1-9. doi:10.5829/idosi.wjms.2020.01.09.
7. Salsabila DA, Sunarno. Identifikasi agen penyakit anthrax pada sediaan apus darah sapi potong di Surakarta. E-journal Binawakya. 2019;14(3):2291-8.
8. Vieira AR, Salzer JS, Traxler RM, Hendrick KA, Kadzik ME, Marston CK, et al. Enhancing surveillance and diagnostics in anthrax-endemic countries. Emerg Infect Dis. 2017;23(13):S147-53. doi:10.3201/eid2313.170431.
9. Mwakapeje ER, Høgset S, Fyumagwa R, Nonga HE, Mdegela RH, Skjerve E. Anthrax outbreaks in the humans - livestock and wildlife interface areas of Northern Tanzania: a retrospective record review 2006-2016. BMC Public Health. 2018;18(106):1-11. doi:10.1186/s12889-017-5007-z.
10. Basri C, Dwidzuriputra S, Sudarnika E. Factors influencing farmers participation in the vaccination program against Anthrax in Bogor District, Indonesia. Acta Vet Indones. 2019;(December):29-34. doi:10.29244/avi.0.0.29-34.
11. Sitali DC, Mumba C, Skjerve E, Mweembe O, Kabonesa C, Mwinyi MO, et al. Awareness and attitudes towards anthrax and meat consumption practices among affected communities in Zambia: A mixed methods approach. PLoS Negl Trop Dis. 2017;11(5):1-18. doi:10.1371/journal.pntd.0005580.
12. Martindah E. Faktor risiko, sikap dan pengetahuan masyarakat peternak dalam pengendalian penyakit antraks. WARTAZOA. 2017;27(3):135-44. doi:10.14334/wartazoa.v27i3.1689.
13. Direktorat Jenderal Pencegahan dan Pengendalian Penyakit. Surat edaran tentang waspada penyakit antraks. Jakarta: Kementerian Kesehatan Republik Indonesia; 2017. 1-2.
14. Doganay M, Demiraslan H. Human anthrax as a re-emerging disease. Recent Pat Antiinfect Drug Discov. 2015;10(1):10-29. doi:10.2174/1574891x10666150408162354.
15. Savransky V, Ionin B, Reece J. Current status and trends in prophylaxis and management of anthrax disease. Pathogens. 2020;9(5):370. doi:10.3390/pathogens9050370.
16. Kementerian Kesehatan Republik Indonesia. Antraks di Yogyakarta sudah teratasi [Internet]; 2017 [Updated 2017 January 25; Cited 2020 May 28]. Available from: http://www.depkes.go.id.
17. Liu Y, Li Y, Wang Q, Fu J, Ji F. Sporadic human cutaneous anthrax outbreak in Shaanxi Province, China: report of two cases from 2018. Brazilian J Infect Dis. 2020;24(1):81-4. doi:10.1016/j.bjid.2019.12.002.
18. Muturi M, Gachohi J, Mwatondo A, Lekolool I, Gakuya F, Bett A, et al. Recurrent anthrax outbreaks in humans, livestock, and wildlife in the same locality, Kenya, 2014-2017. Am J Trop Med Hyg. 2018;99(4):833-9. doi:10.4269/ajtmh.18-0224.
19. Nakanwagi M, Ario AR, Kwagonza L, Aceng FL, Mwesigye J, Bulage L, et al. Outbreak of gastrointestinal anthrax following eating beef of suspicious origin: Isingiro District, Uganda, 2017. PLoS Negl Trop Dis. 2020;14(2):1-12. doi:10.1371/journal.pntd.0008026.
20. Bagenda I, Dariani W, Yudianingtyas DW. Investigasi outbreak penyakit antraks di Kabupaten Polewali Mandar Tahun 2016. Proc. of the 20th FAVA CONGRESS&the 15th KIVNAS PDHI; 2018 Nov 1-3; Bali. Bogor: IPB; 2018.
21. Mwakapeje ER, Høgset S, Softic A, Mghamba J, Nonga HE, Mdegela RH, et al. Risk factors for human cutaneous anthrax outbreaks in the hotspot districts of Northern Tanzania: an unmatched case-control study. R Soc Open Sci. 2018;5(9):1-13. doi:10.1098/rsos.180479.
22. Kutmanova A, Doganay M, Zholdoshev S. Human anthrax in Kyrgyz Republic: epidemiology and clinical features. J Infect Public Health. 2020;13(8):1161-5. doi:10.1016/j.jiph.2020.02.043.
23. Chen WJ, Lai SJ, Yang Y, Liu K, Li XL, Yao HW, et al. Mapping the distribution of anthrax in Mainland China, 2005–2013. PLoS Negl Trop Dis. 2016;10(4):1-15. doi:10.1371/journal.pntd.0004637.
24. Clarasinta C, Soleha TU. Penyakit antraks: ancaman untuk petani dan peternak. Majority. 2017;7(1):158-64.
25. Goel AK. Anthrax: a disease of biowarfare and public health importance. World J Clin Cases. 2015;3(1):20-33. doi:10.12998/wjcc.v3.i1.20.
26. Perry MR, Ionin B, Barnewall RE, Vassar ML, Reece JJ, Park S, et al. Development of a guinea pig inhalational anthrax model for evaluation of post-exposure prophylaxis efficacy of anthrax vaccines. Vaccine. 2020;38(10):2307-14. doi:10.1016/j.vaccine.2020.01.068.
27. Hueffer K, Drown D, Romanovsky V, Hennessy T. Factors contributing to anthrax outbreaks in the Circumpolar North. Ecohealth. 2020;17(1):174-80. doi:10.1007/s10393-020-01474-z.
28. Kim J, Gedi V, Lee SC, Cho JH, Moon JY, Yoon MY. Advances in anthrax detection: overview of bioprobes and biosensors. Appl Biochem Biotechnol. 2015;176:957-77. doi:10.1007/s12010-015-1625-z.
29. Spickler AR. Anthrax [Internet]. The Center for Food Security & Public Health IOWA State University of Science and Technology; 2017 [Updated 2017 December; Cited 2020 July 17]. Available from:http://www.cfsph.iastate.edu/DiseaseInfo/factsheets.php.
30. Sudarmono PP. Biosecurity dalam kedokteran dan kesehatan. eJournal Kedokt Indones. 2015;3(1):1-7. doi:10.23886/ejki.3.4800.
31. Clark A, Wolfe DN. Current state of anthrax vaccines and key r&d gaps moving forward. Microorganisms. 2020;8(5):651. doi:10.3390/microorganisms8050651.
32. Lepheana RJ, Oguttu JW, Qekwana DN. Temporal patterns of anthrax outbreaks among livestock in Lesotho, 2005-2016. PLoS One. 2018;13(10):e0204758. doi:10.1371/journal.pone.0204758.
33. Kasradze A, Echeverria D, Zakhashvili K, Bautista C, Heyer N, Imnadze P, et al. Rates and risk factors for human cutaneous anthrax in the country of Georgia: national surveillance data, 2008–2015. PLoS One. 2018;13(2):1-9. doi:10.1371/journal.pone.0192031.
34. Centers for Disease Control and Prevention. Guide to understanding anthrax infectious disease-anthrax [Internet]; 2016 [Updated 2016 May; Cited 2020 May 25]. 1-9. Available from: http://www.cdc.gov.
35. Dumas EK, Demiraslan H, Ingram RJ, Spark RM, Muns E, Zamora A, et al. Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes. PLoS One. 2020;15(4):1-17. doi:10.1371/journal.pone.0230782.
36. Kansas Department of Health and Environment. Anthrax investigation guideline [Internet]; 2018 [Updated 2018 January 1; Cited 2020 July 16]. 1-20. Available from://www.kdheks.gov.
37. McLaughlin HP, Bugrysheva JV, Conley AB, Gulvik CA, Cherney B, Kolton CB, et al. Rapid nanopore whole-genome sequencing for anthrax emergency preparedness. Emerg Infect Dis. 2020;26(2):358-61. doi:10.3201/eid2602.191351.
38. Kementerian Kesehatan Republik Indonesia. Profil Kesehatan Indonesia Tahun 2017. Jakarta: Kementerian Kesehatan RI; 2018. 1-496.
39. Kementerian Kesehatan Republik Indonesia. Profil Kesehatan Indonesia Tahun 2018. Jakarta: Kementerian Kesehatan RI; 2019. 1-556.
40. Makhija S, Sumit K, Hossain S. Risk factor associated with anthrax transmission among the Tribal Communities of Odisha. Indian Journal of Public Health Research& Development. 2020;11(1):603-8.
41. Winarsih WH. Penyakit ternak yang perlu diwaspadai terkait keamanan pangan. Cakrawala. 2018;12(2):208-21. doi:10.32781/cakrawala.v12i2.270.
42. Direktorat Jenderal Peternakan dan Kesehatan Hewan. Pedoman pengendalian dan pemberantasan penyakit hewan menular (PHM) - seri penyakit antraks. Jakarta: Kementerian Pertanian Republik Indonesia; 2016: 1-46.
43. Ghaderi E, Mohsenpour B, Moradi G, Karimi M, Najafi F, Nili S, et al. Spatial distribution of cutaneous anthrax in western Iran from 2009 to 2016: geographic information system mapping for predicting risk of anthrax outbreaks. Asian Pac J Trop Med. 2020;13(5):227-34. doi:10.4103/1995-7645.283516.
44. Morris LR, Blackburn JK. Predicting disease risk, identifying stakeholders, and informing control strategies : a case study of anthrax in Montana. Ecohealth. 2016;13(2):262-73. doi:10.1007/s10393-016-1119-7.
Copyright (c) 2020 BALABA
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The Authors submitting a manuscript do so on the understanding that if accepted for publication, the copyright of the article shall be assigned to BALABA .
Copyright encompasses exclusive rights to reproduce and deliver the article in all forms and media, including reprints, photographs, microfilms, and any other similar reproductions, as well as translations. The reproduction of any part of this journal, its storage in databases, and its transmission by any form or media, such as electronic, electrostatic, and mechanical copies, photocopies, recordings, magnetic media, etc., will be allowed only with written permission from BALABA.
BALABA, the Editors, and the Editorial Board make every effort to ensure that no wrong or misleading data, opinions or statements be published in this journal.
Click here to download Copyright Transfer Form.
